Loading…

Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40

Protozoa of the genus Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with L. major in mice indicates that a protective immune response is achieved...

Full description

Saved in:
Bibliographic Details
Published in:Immunology Letters 2006-05, Vol.105 (1), p.38-47
Main Authors: Hernández S., Mayra Xiomara, Barçante, Thales Augusto, Vilela, Luciano, Tafuri, Wagner Luiz, Afonso, Luís Carlos Crocco, Vieira, Leda Quercia
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383
cites
container_end_page 47
container_issue 1
container_start_page 38
container_title Immunology Letters
container_volume 105
creator Hernández S., Mayra Xiomara
Barçante, Thales Augusto
Vilela, Luciano
Tafuri, Wagner Luiz
Afonso, Luís Carlos Crocco
Vieira, Leda Quercia
description Protozoa of the genus Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with L. amazonensis and after vaccination with Leishvacin ® (killed Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40 −/−) and wild-type controls (wt) were infected with L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40 −/− mice were more susceptible to L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40 −/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against L. amazonensis infection, IL-12p40 −/− wt mice were vaccinated in the base of the tail and subsequently challenged with L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40 −/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40 −/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.
doi_str_mv 10.1016/j.imlet.2005.12.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67963859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165247805003883</els_id><sourcerecordid>17178813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383</originalsourceid><addsrcrecordid>eNqFkUFLJDEQhYO4OKPrLxAkJ2_dJpWkO33wIOKuwoCX3b2GdLriZJhOj50ewf31ZpwBbwoFdfneK-o9Qi44Kznj1fWqDP0apxIYUyWHkjE4InOu66ZgSsIxmWdKFSBrPSOnKa0Y40pIcUJmvJJVpTmbE_fPOhciFiF2W4cd3YzDhG4KQ6T22YaYJrrAkJa9jcFS29v_Q8SYQqJ5hnbKSFaFSKclUtsmjA7p4OnjouBwDWIj2U_yw9t1wvPDPiN_f93_uXsoFk-_H-9uF4WTQkxF5UE2qKRXYL2wFqQWIFqPDXQWvPO6dh3UulEATrUVl8iEh7rhvkMUWpyRq71v_uFli2kyfUgO12sbcdgmU9VNJbRqvgV5zWutucig2INuHFIa0ZvNGHo7vhnOzK4EszIfJZhdCYaDySVk1eXBftv22H1qDqln4GYPYE7jNeBokgu74Low5uxNN4QvD7wDZ7yYnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17178813</pqid></control><display><type>article</type><title>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</title><source>Wiley</source><source>Elsevier</source><source>PubMed Central</source><creator>Hernández S., Mayra Xiomara ; Barçante, Thales Augusto ; Vilela, Luciano ; Tafuri, Wagner Luiz ; Afonso, Luís Carlos Crocco ; Vieira, Leda Quercia</creator><creatorcontrib>Hernández S., Mayra Xiomara ; Barçante, Thales Augusto ; Vilela, Luciano ; Tafuri, Wagner Luiz ; Afonso, Luís Carlos Crocco ; Vieira, Leda Quercia</creatorcontrib><description>Protozoa of the genus Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with L. amazonensis and after vaccination with Leishvacin ® (killed Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40 −/−) and wild-type controls (wt) were infected with L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40 −/− mice were more susceptible to L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40 −/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against L. amazonensis infection, IL-12p40 −/− wt mice were vaccinated in the base of the tail and subsequently challenged with L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40 −/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40 −/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.</description><identifier>ISSN: 0165-2478</identifier><identifier>EISSN: 1879-0542</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.1016/j.imlet.2005.12.002</identifier><identifier>PMID: 16466810</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adjuvant ; Animals ; Female ; IL-12 ; Interferon-gamma - biosynthesis ; Interleukin-12 - deficiency ; Interleukin-12 - genetics ; Interleukin-12 Subunit p40 ; Interleukin-4 - biosynthesis ; Leishmania ; Leishmania amazonensis ; Leishmania mexicana - immunology ; Leishmaniasis ; Leishmaniasis, Cutaneous - immunology ; Leishmaniasis, Cutaneous - pathology ; Leishmaniasis, Cutaneous - prevention &amp; control ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Parasite ; Protein Subunits - deficiency ; Protein Subunits - genetics ; Protozoa ; Protozoan Vaccines - pharmacology ; Vaccine</subject><ispartof>Immunology Letters, 2006-05, Vol.105 (1), p.38-47</ispartof><rights>2006 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16466810$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernández S., Mayra Xiomara</creatorcontrib><creatorcontrib>Barçante, Thales Augusto</creatorcontrib><creatorcontrib>Vilela, Luciano</creatorcontrib><creatorcontrib>Tafuri, Wagner Luiz</creatorcontrib><creatorcontrib>Afonso, Luís Carlos Crocco</creatorcontrib><creatorcontrib>Vieira, Leda Quercia</creatorcontrib><title>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</title><title>Immunology Letters</title><addtitle>Immunol Lett</addtitle><description>Protozoa of the genus Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with L. amazonensis and after vaccination with Leishvacin ® (killed Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40 −/−) and wild-type controls (wt) were infected with L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40 −/− mice were more susceptible to L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40 −/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against L. amazonensis infection, IL-12p40 −/− wt mice were vaccinated in the base of the tail and subsequently challenged with L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40 −/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40 −/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.</description><subject>Adjuvant</subject><subject>Animals</subject><subject>Female</subject><subject>IL-12</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Interleukin-12 - deficiency</subject><subject>Interleukin-12 - genetics</subject><subject>Interleukin-12 Subunit p40</subject><subject>Interleukin-4 - biosynthesis</subject><subject>Leishmania</subject><subject>Leishmania amazonensis</subject><subject>Leishmania mexicana - immunology</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis, Cutaneous - immunology</subject><subject>Leishmaniasis, Cutaneous - pathology</subject><subject>Leishmaniasis, Cutaneous - prevention &amp; control</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Parasite</subject><subject>Protein Subunits - deficiency</subject><subject>Protein Subunits - genetics</subject><subject>Protozoa</subject><subject>Protozoan Vaccines - pharmacology</subject><subject>Vaccine</subject><issn>0165-2478</issn><issn>1879-0542</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkUFLJDEQhYO4OKPrLxAkJ2_dJpWkO33wIOKuwoCX3b2GdLriZJhOj50ewf31ZpwBbwoFdfneK-o9Qi44Kznj1fWqDP0apxIYUyWHkjE4InOu66ZgSsIxmWdKFSBrPSOnKa0Y40pIcUJmvJJVpTmbE_fPOhciFiF2W4cd3YzDhG4KQ6T22YaYJrrAkJa9jcFS29v_Q8SYQqJ5hnbKSFaFSKclUtsmjA7p4OnjouBwDWIj2U_yw9t1wvPDPiN_f93_uXsoFk-_H-9uF4WTQkxF5UE2qKRXYL2wFqQWIFqPDXQWvPO6dh3UulEATrUVl8iEh7rhvkMUWpyRq71v_uFli2kyfUgO12sbcdgmU9VNJbRqvgV5zWutucig2INuHFIa0ZvNGHo7vhnOzK4EszIfJZhdCYaDySVk1eXBftv22H1qDqln4GYPYE7jNeBokgu74Low5uxNN4QvD7wDZ7yYnw</recordid><startdate>20060515</startdate><enddate>20060515</enddate><creator>Hernández S., Mayra Xiomara</creator><creator>Barçante, Thales Augusto</creator><creator>Vilela, Luciano</creator><creator>Tafuri, Wagner Luiz</creator><creator>Afonso, Luís Carlos Crocco</creator><creator>Vieira, Leda Quercia</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20060515</creationdate><title>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</title><author>Hernández S., Mayra Xiomara ; Barçante, Thales Augusto ; Vilela, Luciano ; Tafuri, Wagner Luiz ; Afonso, Luís Carlos Crocco ; Vieira, Leda Quercia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adjuvant</topic><topic>Animals</topic><topic>Female</topic><topic>IL-12</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Interleukin-12 - deficiency</topic><topic>Interleukin-12 - genetics</topic><topic>Interleukin-12 Subunit p40</topic><topic>Interleukin-4 - biosynthesis</topic><topic>Leishmania</topic><topic>Leishmania amazonensis</topic><topic>Leishmania mexicana - immunology</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis, Cutaneous - immunology</topic><topic>Leishmaniasis, Cutaneous - pathology</topic><topic>Leishmaniasis, Cutaneous - prevention &amp; control</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Parasite</topic><topic>Protein Subunits - deficiency</topic><topic>Protein Subunits - genetics</topic><topic>Protozoa</topic><topic>Protozoan Vaccines - pharmacology</topic><topic>Vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernández S., Mayra Xiomara</creatorcontrib><creatorcontrib>Barçante, Thales Augusto</creatorcontrib><creatorcontrib>Vilela, Luciano</creatorcontrib><creatorcontrib>Tafuri, Wagner Luiz</creatorcontrib><creatorcontrib>Afonso, Luís Carlos Crocco</creatorcontrib><creatorcontrib>Vieira, Leda Quercia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Immunology Letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernández S., Mayra Xiomara</au><au>Barçante, Thales Augusto</au><au>Vilela, Luciano</au><au>Tafuri, Wagner Luiz</au><au>Afonso, Luís Carlos Crocco</au><au>Vieira, Leda Quercia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</atitle><jtitle>Immunology Letters</jtitle><addtitle>Immunol Lett</addtitle><date>2006-05-15</date><risdate>2006</risdate><volume>105</volume><issue>1</issue><spage>38</spage><epage>47</epage><pages>38-47</pages><issn>0165-2478</issn><eissn>1879-0542</eissn><eissn>1365-2567</eissn><abstract>Protozoa of the genus Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with L. amazonensis and after vaccination with Leishvacin ® (killed Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40 −/−) and wild-type controls (wt) were infected with L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40 −/− mice were more susceptible to L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40 −/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against L. amazonensis infection, IL-12p40 −/− wt mice were vaccinated in the base of the tail and subsequently challenged with L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40 −/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40 −/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>16466810</pmid><doi>10.1016/j.imlet.2005.12.002</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0165-2478
ispartof Immunology Letters, 2006-05, Vol.105 (1), p.38-47
issn 0165-2478
1879-0542
1365-2567
language eng
recordid cdi_proquest_miscellaneous_67963859
source Wiley; Elsevier; PubMed Central
subjects Adjuvant
Animals
Female
IL-12
Interferon-gamma - biosynthesis
Interleukin-12 - deficiency
Interleukin-12 - genetics
Interleukin-12 Subunit p40
Interleukin-4 - biosynthesis
Leishmania
Leishmania amazonensis
Leishmania mexicana - immunology
Leishmaniasis
Leishmaniasis, Cutaneous - immunology
Leishmaniasis, Cutaneous - pathology
Leishmaniasis, Cutaneous - prevention & control
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Parasite
Protein Subunits - deficiency
Protein Subunits - genetics
Protozoa
Protozoan Vaccines - pharmacology
Vaccine
title Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A06%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccine-induced%20protection%20against%20Leishmania%20amazonensis%20is%20obtained%20in%20the%20absence%20of%20IL-12/23p40&rft.jtitle=Immunology%20Letters&rft.au=Hern%C3%A1ndez%20S.,%20Mayra%20Xiomara&rft.date=2006-05-15&rft.volume=105&rft.issue=1&rft.spage=38&rft.epage=47&rft.pages=38-47&rft.issn=0165-2478&rft.eissn=1879-0542&rft_id=info:doi/10.1016/j.imlet.2005.12.002&rft_dat=%3Cproquest_cross%3E17178813%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17178813&rft_id=info:pmid/16466810&rfr_iscdi=true